Everest Group's Quarterly Earnings Preview: What You Need to Know

Valued at a market cap of $14.5 billion, Everest Group, Ltd. (EG) is a global provider of reinsurance and insurance products through its Insurance and Reinsurance segments. The company offers a wide range of property and casualty, specialty, and commercial insurance solutions across the United States, Europe, and other international markets. EG is expected to announce its fiscal Q2 2025 earnings results after the market closes on Wednesday, Jul. 30. 

Ahead of this event, analysts expect the Hamilton, Bermuda-based company to report an adjusted earnings of $15.17 per share, down nearly 10% from $16.85 per share in the year-ago quarter. The company has surpassed Wall Street's earnings estimates in one of the last four quarters while missing on three other occasions. 

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

For fiscal 2025, analysts expect the reinsurance company to report an adjusted EPS of $45.27, up 51.8% from $29.83 in fiscal 2024. 

www.barchart.com

EG stock has declined nearly 10% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 11.5% rise and the Financial Select Sector SPDR Fund's (XLF) nearly 24% return over the same period. 

www.barchart.com

Shares of Everest Group tumbled nearly 6% following its Q1 2025 results on Apr. 30 due to a steep 71% drop in net income to $210 million ($4.90 per share). The company posted a significant pre-tax catastrophe loss of $472 million, primarily from California wildfires, which contributed to a deteriorated combined ratio of 102.7%. Both adjusted EPS of $6.45 and revenue of $4.3 billion, missed Wall Street expectations. 

Analysts' consensus view on Everest Group’s stock is cautiously optimistic, with a "Moderate Buy" rating overall. Among 14 analysts covering the stock, six recommend "Strong Buy," one "Moderate Buy," six suggest "Hold," and one has a "Strong Sell." This configuration is slightly more bullish than three months ago, with five analysts suggesting a "Strong Buy." 

As of writing, the stock is trading below the average analyst price target of $393.62.